VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity.
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity. Mol Ther. 2021 05 05; 29(5):1808-1820.
View in:
PubMed
subject areas
A549 Cells
Animals
Antibodies, Monoclonal
B7-H1 Antigen
Cell Line, Tumor
Combined Modality Therapy
Dependovirus
Helper Viruses
Humans
Immunotherapy, Adoptive
Interleukin-12
Lung Neoplasms
Mesenchymal Stem Cell Transplantation
Oncolytic Virotherapy
Receptor, ErbB-2
Receptors, Antigen, T-Cell
Tumor Microenvironment
Viral Tropism
Xenograft Model Antitumor Assays
authors with profiles
MASATAKA SUZUKI
MALCOLM BRENNER
VALENTINA HOYOS
MARY MCKENNA